This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2010-2011.
Company Filing History:
Years Active: 2010-2011
Title: Hiroko Konishi: Innovator in Antibody Development
Introduction
Hiroko Konishi is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. With a total of 2 patents, her work has the potential to impact cancer treatment and diagnostics.
Latest Patents
Hiroko Konishi's latest patents include an anti-glypican 3 antibody and a stabilized antibody-containing preparation. The anti-glypican 3 antibody is capable of binding to a specific region of glypican 3. This antibody exhibits higher antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) activity compared to conventional antibodies. It is useful as a cell growth inhibitor, anticancer agent, and diagnostic tool for cancers. The stabilized preparation contains acetyltryptophan or its derivatives as a stabilizer, which helps maintain the biological activity of the antibody.
Career Highlights
Hiroko Konishi is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her work at Chugai has allowed her to focus on groundbreaking research in antibody development.
Collaborations
Some of her notable coworkers include Kiyotaka Nakano and Takeshi Yoshino, who have collaborated with her on various projects.
Conclusion
Hiroko Konishi's innovative work in antibody development showcases her dedication to advancing cancer treatment and diagnostics. Her contributions are paving the way for future breakthroughs in biotechnology.